Uwe Reusch

Mannheim, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS.

The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS.

Journal: Nature communications
Published: February 21, 2024

Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers.

Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers.

Journal: Antibodies (Basel, Switzerland)
Published: December 20, 2021

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.

Journal: Leukemia
Published: August 05, 2021

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors.

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors.

Journal: mAbs
Published: July 30, 2021

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity.

Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity.

Journal: mAbs
Published: June 08, 2019

Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11.

Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 16, 2019

CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells.

CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells.

Journal: Cancer immunology research
Published: September 27, 2017

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.

Journal: Frontiers in oncology
Published: February 01, 2017

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells.

Journal: Protein engineering, design & selection : PEDS
Published: December 28, 2016

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia.

Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 06, 2016

LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.

LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD
Published: October 21, 2015

Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.

Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.

Journal: PloS one
Published: July 22, 2015
Showing 1-12 of 24

Last Updated: 09/26/2026